Format

Send to

Choose Destination
Blood Cells Mol Dis. 2013 Jun;51(1):17-21. doi: 10.1016/j.bcmd.2013.02.003. Epub 2013 Mar 1.

Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.

Author information

1
Department of Molecular Medicine and Medical Biotechnologies, University Federico II of Naples, Naples, Italy.

Abstract

Congenital dyserythropoietic anemia type II, a recessive disorder of erythroid differentiation, is due to mutations in SEC23B, a component of the core trafficking machinery COPII. In no case homozygosity or compound heterozygosity for nonsense mutation(s) was found. This study represents the first description of molecular mechanisms underlying SEC23B hypomorphic genotypes by the analysis of five novel mutations. Our findings suggest that reduction of SEC23B gene expression is not associated with CDA II severe clinical presentation; conversely, the combination of a hypomorphic allele with one functionally altered results in more severe phenotypes. We propose a mechanism of compensation SEC23A-mediated which justifies these observations.

PMID:
23453696
PMCID:
PMC3651933
DOI:
10.1016/j.bcmd.2013.02.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center